Jeffrey Venstrom: We are excited to announce a new research collaboration with Whitman-Walker and Cancer Support Community, aimed at advancing health equity in cancer screening with MCED.

Jeffrey Venstrom, Chief Medical Officer at GRAIL, made the following post on LinkedIn:

“Cancer screening only works if it is accessible to those who need it. Multi-cancer early detection through a simple blood test holds promise for addressing access to screening, but there is more to learn about navigating access barriers, particularly for underserved populations.

We are excited to announce a new research collaboration with Whitman-Walker and Cancer Support Community, aimed at advancing health equity in cancer screening with MCED. The INCLUDE study will evaluate how MCED can be implemented in a diverse, real-world population of underserved patients to increase early cancer detection.”

For details click here.
Source: Jeffrey Venstrom, M.D. / LinkedIn